Impact on the medical decision-making process of multiplex PCR assay for respiratory pathogens

A Guillon1, S Aymeric2, C Gaudy-Graffin3

  • 1Service de Réanimation Polyvalente,CHRU de Tours,Université François Rabelais,CEPR, U1100, Tours,France.

Insights

Multiplex PCR assays (MPAs) significantly changed community-acquired pneumonia (CAP) diagnosis. However, their impact on clinical decisions varied widely across different hospital units.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) diagnosis traditionally relies on identifying causative pathogens.
  • Modern advancements include multiplex PCR assays (MPAs) for rapid, broad-spectrum pathogen detection.
  • Understanding the clinical integration of MPAs in CAP management is crucial.

Purpose of the Study:

  • To evaluate the utilization of multiplex PCR assays (MPAs) in managing hospitalized CAP patients.
  • To assess the impact of MPAs on the diagnostic approach to CAP etiology.
  • To investigate variations in MPA contribution to clinical decision-making across different care units.

Main Methods:

  • Retrospective analysis of 1648 hospitalized CAP patients over a 3-year period.
  • Data collected during the initial implementation phase of MPAs.
  • Comparison of MPA usage and impact across various hospital departments.

Main Results:

  • MPAs represent a significant shift in identifying multiple respiratory pathogens for CAP.
  • The clinical utility of MPAs in guiding patient management was not uniform.
  • Substantial variability was observed in how MPAs influenced medical decisions depending on the unit.

Conclusions:

  • MPAs have fundamentally altered the etiological investigation of CAP.
  • Clinical decision-making integration of MPAs requires further optimization.
  • Care setting significantly influences the effective application of MPAs in CAP management.